Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Takeda
Pharma
Licensing deals, AI pact and Novo vs. KBP—Fierce Pharma Asia
Dianthus and Boehringer headlined the latest round of licensing deals featuring China biotechs. Takeda inked its second pact with Nabla Bio. And more.
Eric Sagonowsky
Oct 17, 2025 9:40am
Fierce Biotech
BioCryst inks $700M Astria deal to rival Takeda in rare disease
Oct 14, 2025 10:30am
Novo-KBP, Takeda, Enhertu—Fierce Pharma Asia
Oct 2, 2025 4:02pm
Celltrion buy, Rexulti CRL, Glenmark-Hengrui—Fierce Pharma Asia
Sep 26, 2025 10:00am
Takeda plasma-derived therapies team tackles Mount Fuji
Sep 19, 2025 3:22pm
China deals, Daiichi-Merck ADC, Sun Pharma—Fierce Pharma Asia
Sep 11, 2025 8:50pm
